Teva Pharmaceutical Industries Aktie

Handeln
14,00 EUR +0,15 EUR +1,08 %
16,44 USD +0,03 USD +0,18 %
nachbörslich
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone
Div. Rendite 0,00%
WKN wurde kopiert

NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker

WKN 883035

ISIN wurde kopiert

NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker

ISIN US8816242098

Symbol wurde kopiert

NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker

Symbol TEVA


Teva Pharmaceutical Industries Aktie Analyse

03.08.11 Teva Pharmaceutical Industries buy UBS AG
03.08.11 Teva Pharmaceutical Industries buy UBS AG
29.07.11 Teva Pharmaceutical Industries outperform RBC Capital Markets
28.07.11 Teva Pharmaceutical Industries buy UBS AG
26.07.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
19.07.11 Teva Pharmaceutical Industries buy Citigroup Corp.
23.05.11 Teva Pharmaceutical Industries kaufen Die Actien-Börse
17.05.11 Teva Pharmaceutical Industries buy Citigroup Corp.
12.05.11 Teva Pharmaceutical Industries buy UBS AG
06.05.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
03.05.11 Teva Pharmaceutical Industries buy UBS AG
26.04.11 Teva Pharmaceutical Industries buy UBS AG
13.04.11 Teva Pharmaceutical Industries overweight Barclays Capital
07.04.11 Teva Pharmaceutical Industries overweight Barclays Capital
04.04.11 Teva Pharmaceutical Industries neutral Credit Suisse Group
28.03.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
28.03.11 Teva Pharmaceutical Industries overweight Barclays Capital
25.03.11 Teva Pharmaceutical Industries neutral Credit Suisse Group
21.03.11 Teva Pharmaceutical Industries overweight Barclays Capital
09.02.11 Teva Pharmaceutical Industries buy UBS AG
09.02.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
08.02.11 Teva Pharmaceutical Industries overweight Barclays Capital
07.02.11 Teva Pharmaceutical Industries neutral Credit Suisse Group
03.02.11 Teva Pharmaceutical Industries buy UBS AG
02.02.11 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
26.01.11 Teva Pharmaceutical Industries neutral Credit Suisse Group
26.01.11 Teva Pharmaceutical Industries buy UBS AG
14.01.11 Teva Pharmaceutical Industries halten Nasd@q Inside
21.12.10 Teva Pharmaceutical Industries overweight Barclays Capital
10.12.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
27.10.10 Teva Pharmaceutical Industries overweight Barclays Capital
25.10.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
19.10.10 Teva Pharmaceutical Industries overweight Barclays Capital
08.10.10 Teva Pharmaceutical Industries neutral Nasd@q Inside
10.09.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
09.09.10 Teva Pharmaceutical Industries outperform Oppenheimer & Co. Inc.
19.08.10 Teva Pharmaceutical Industries buy Citigroup Corp.
03.08.10 Teva Pharmaceutical Industries overweight Barclays Capital
02.08.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
26.07.10 Teva Pharmaceutical Industries outperform RBC Capital Markets
20.07.10 Teva Pharmaceutical Industries buy Société Générale Group S.A. (SG)
20.07.10 Teva Pharmaceutical Industries overweight Piper Jaffray & Co.
12.07.10 Teva Pharmaceutical Industries kaufen UBS AG
08.07.10 Teva Pharmaceutical Industries kaufen Société Générale Group S.A. (SG)
30.06.10 Teva Pharmaceutical Industries stark kaufen Needham & Company, LLC
24.06.10 Teva Pharmaceutical Industries kaufen Société Générale Group S.A. (SG)
27.05.10 Teva Pharmaceutical Industries kaufen Citigroup Corp.
18.05.10 Teva Pharmaceutical Industries halten Jefferies & Company Inc.
13.05.10 Teva Pharmaceutical Industries halten Oppenheimer & Co. Inc.
03.05.10 Teva Pharmaceutical Industries kaufen Barclays Capital
Werbung